Natco Pharma shares will be in focus of the stock market investors on Thursday after the ₹2,000 crore acquisition move. The ...

Natco Pharma to acquire 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore, marking its entry into the African ...

Natco Pharma to acquire 35.75% stake in South Africa’s Adcock Ingram for ₹1,970 crore in cash; move aimed at expanding global ...

Natco Pharma Ltd. on Wednesday, July 23, announced the acquisition of a 35.75% stake in South Africa-based Adcock Ingram ...

Should the offer be accepted, the company will hold a 35.75 per cent stake in the South Africa firm, valued at R4 billion ...

Natco Pharma to acquire 36% stake in Adcock Ingram Holdings for $226 million, expanding presence in South Africa.

Adcock Ingram offers generics and OTC medicines in Africa. CNBC-Awaaz reported that Natco may buy majority stake in the firm ...

Hyderabad: NATCO Pharma Limited has submitted a firm intention offer to Adcock Ingram Holdings Limited, a South African ...

Natco Pharma has proposed to acquire a 35.75% stake in South African Adcock Ingram Holdings for Rs 2,100 crore. This move ...

NATCO Pharma Limited announced that its Board of Directors has approved the acquisition of 51,643,319 shares, representing 35.75% of Adcock Ingram Holdings Limited, South Africa, for a cash offer of ...

Natco Pharma offers to buy nearly 36% stake in Adcock Ingram Holdings for up to Rs 2,100 crore ($226 million). This acquisition will expand Natco's presence in the Southern African market.

Natco Pharma informed that the U.S. Food and Drug Administration (US FDA) has issued an EIR for its active pharmaceutical ingredient (API) division located in Mekaguda, Hyderabad, Telangana.